VRTX R&D Expenses
Vertex Pharmaceuticals · R&D Expenses
VRTX R&D Expenses
Latest reported$3.96Bperiod ending
VRTX R&D Expenses ($0.00 → $3.96B)
Annual R&D Expenses
High-resolution chart · PNG
VRTX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 3,753,700,000 | |
| 3,630,300,000 | |
| 3,162,900,000 | |
| 2,655,800,000 | |
| 3,051,100,000 | |
| 1,829,537,000 | |
| 1,754,540,000 | |
| 1,416,476,000 | |
| 1,324,625,000 | |
| 1,047,690,000 | |
| 996,170,000 | |
| 855,506,000 | |
| 918,783,000 | |
| 806,185,000 | |
| 707,706,000 | |
| 637,416,000 | |
| 550,685,000 | |
| 516,292,000 | |
| 513,054,000 | |
| 371,713,000 | |
| 248,540,000 | |
| 192,162,000 | |
| 199,636,000 | |
| 203,018,000 | |
| 148,673,000 | |
| 84,921,000 | |
| 72,200,000 | |
| 58,700,000 | |
| 51,600,000 | |
| 35,200,000 | |
| 41,500,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |